Clinical trials
Phase 3 Sepsis trials in France
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
25 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 2 |
| 2003 | 1 |
| 2004 | 1 |
| 2006 | 1 |
| 2007 | 1 |
| 2008 | 3 |
| 2012 | 2 |
| 2013 | 1 |
| 2015 | 2 |
| 2016 | 2 |
| 2018 | 3 |
| 2020 | 3 |
| 2023 | 2 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 18 |
| Recruiting | 2 |
| Terminated | 2 |
| Unknown status | 2 |
| Not yet recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Eli Lilly and Company | 4 |
| Assistance Publique - Hôpitaux de Paris | 3 |
| Hospices Civils de Lyon | 3 |
| Asahi Kasei Pharma America Corporation | 1 |
| Assistance Publique Hopitaux De Marseille | 1 |
| Central Hospital, Nancy, France | 1 |
| Centre Hospitalier Universitaire de Besancon | 1 |
| Centre Hospitalier Universitaire de Nīmes | 1 |
| Cidara Therapeutics Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | 1 |
| Eisai Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Sepsis | 25 |
| Shock, Septic | 8 |
| Infections | 3 |
| Candidemia | 2 |
| Candidiasis | 2 |
| Candidiasis, Invasive | 2 |
| Critical Illness | 2 |
| Fungemia | 2 |
| Invasive Fungal Infections | 2 |
| Mycoses | 2 |
Trials
Showing 1 to 25 of 25. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.